Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose dexamethasone plus ulinastatin to prevent SIRS after holmium laser lithotripsy
ChiCTR2500103934Phase 4Recruiting
- Sponsor
- Leshan People's Hospital
- Start
- Jun 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4 trial of dexamethasone and ulinastatin in Systemic Inflammatory Response Syndrome (SIRS) and upper urinary tract calculi (UUTC) (3 arms), sponsored by Leshan People's Hospital. Primary endpoints: White blood cell count, Procalcitonin and 2 more. Started Jun 2025; status: recruiting.
02
Drugs
dexamethasoneulinastatin
03
Conditions
Systemic Inflammatory Response Syndrome (SIRS)upper urinary tract calculi (UUTC)
Beyond the preview
Go deeper on ChiCTR2500103934.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500103934.